Unconventional regulation of mTORC1 signaling by inositol phosphate: implications for nutrient-induced premature aging

磷酸肌醇对 mTORC1 信号传导的非常规调节:对营养诱导的过早衰老的影响

基本信息

项目摘要

Nutrient accelerates cellular aging processes through metabolic stress. The detrimental effects of nutrient overload to health span are partially mediated by mTORC1 (mechanistic Target of Rapamycin Complex 1), an evolutionarily conserved nutrient-sensing kinase that signals for increase in anabolic processes. mTORC1 activity has been directly linked to aging and age-associated diseases in a diverse range of organisms including humans, mice, flies and worms. Remarkably, genetic or pharmacological inhibition of mTORC1 improved the health and increased the lifespan of several animal models of premature aging. Although the molecular mechanisms for mTORC1 activation by amino acids and growth factors are well established, recent findings indicate that excess glucose stimulates mTORC1 signaling through unconventional mechanisms that are not completely understood. Glucose metabolism directly and indirectly stimulates the production of the small metabolite inositol hexakisphosphate (IP6). Recent structural studies revealed that IP6 is tightly associated with mTOR, the catalytic subunit of mTORC1. Preliminary data suggest that IP6 binding to mTOR stabilizes the in vitro association between mTOR and RAPTOR, the regulatory subunit of mTORC1. The goal of this proposal is to establish a role for IP6 in the regulation of mTORC1 signaling in vivo and to assess whether targeting the metabolic pathways for IP6 synthesis will prevent cellular aging and promote longevity. In specific aim 1, the impact of IP6 metabolism on mTOR signaling and cellular ageing will be investigated. IP6 synthesis will be manipulated by suppression of the two critical kinases that catalyze the synthesis of IP6 – IPMK and IPK1. In addition we will suppress ISYNA1, the enzyme that catalyzes de novo synthesis of inositol from glucose. The direct effects of cellular IP6 on mTORC1/2 complex assembly and stability will be examined using recombinant mTOR mutants that are unable to bind to IP6. In specific aim 2, the crosstalk between IP6 metabolism and mTORC1 signaling will be genetically tested using C. elegans as a model for assessing longevity. Epistasis studies will be performed to determine how IPMK and IPK1 interact with of mTORC1. Suppression of enzymes involved in IP6 synthesis are predicted to protect worms from mTORC1- induced premature aging. Understanding the impact of IP6 on mTORC1 signaling and in aging will open up new opportunities for targeting these pathways to improve health.
营养素通过代谢压力加速细胞衰老过程。营养素的有害影响 超负荷的健康寿命部分由mTORC 1(雷帕霉素复合物1的机制靶点)介导, 一种进化上保守的营养感应激酶,发出合成代谢过程增加的信号。mTORC1 在多种生物体中,活性与衰老和与年龄相关的疾病直接相关 包括人类、老鼠、苍蝇和蠕虫。值得注意的是,mTORC 1的遗传或药理学抑制 改善了几种早衰动物模型的健康状况并延长了寿命。虽然 氨基酸和生长因子激活mTORC 1的分子机制已经很好地建立,最近 研究结果表明,过量的葡萄糖通过非常规机制刺激mTORC 1信号传导, 还没有完全被理解。葡萄糖代谢直接或间接地刺激产生 小代谢产物肌醇六磷酸(IP 6)。最近的结构研究表明,IP 6是紧密的, 与mTOR相关,mTORC 1的催化亚基。初步数据表明,IP 6与mTOR的结合 稳定mTOR和RAPTOR(mTORC 1的调节亚基)之间的体外结合。目标 该建议的目的是建立IP 6在体内mTORC 1信号转导调节中的作用,并评估 针对IP 6合成的代谢途径是否会防止细胞衰老并促进长寿。 在具体目标1中,将研究IP 6代谢对mTOR信号传导和细胞老化的影响。 通过抑制催化IP 6合成的两种关键激酶来操纵IP 6合成 - IPMK和IPK 1。此外,我们将抑制ISYNA 1,这种酶催化从头合成的 肌醇从葡萄糖。细胞IP 6对mTORC 1/2复合物组装和稳定性的直接影响将在下文中讨论。 使用不能与IP 6结合的重组mTOR突变体进行检查。在具体目标2中,串扰 将使用C.作为一种模式, 评估寿命。将进行上位性研究,以确定IPMK和IPK 1如何与 mTORC 1。预测抑制参与IP 6合成的酶可保护蠕虫免受mTORC 1- 导致过早衰老。了解IP 6对mTORC 1信号传导和衰老的影响将打开 为这些途径提供新的机会,以改善健康。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raymond Daniel Blind其他文献

Raymond Daniel Blind的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raymond Daniel Blind', 18)}}的其他基金

Unconventional regulation of mTORC1 signaling by inositol phosphate: implications for nutrient-induced premature aging
磷酸肌醇对 mTORC1 信号传导的非常规调节:对营养诱导的过早衰老的影响
  • 批准号:
    10372324
  • 财政年份:
    2022
  • 资助金额:
    $ 18.84万
  • 项目类别:
IPMK function in chromatin
IPMK 在染色质中的功能
  • 批准号:
    10350670
  • 财政年份:
    2020
  • 资助金额:
    $ 18.84万
  • 项目类别:
Full-length LRH-1 structural regulation
全长LRH-1结构调整
  • 批准号:
    10034145
  • 财政年份:
    2020
  • 资助金额:
    $ 18.84万
  • 项目类别:
Full-length LRH-1 structural regulation
全长LRH-1结构调整
  • 批准号:
    10245137
  • 财政年份:
    2020
  • 资助金额:
    $ 18.84万
  • 项目类别:
IPMK function in chromatin
IPMK 在染色质中的功能
  • 批准号:
    9973484
  • 财政年份:
    2020
  • 资助金额:
    $ 18.84万
  • 项目类别:
IPMK function in chromatin
IPMK 在染色质中的功能
  • 批准号:
    10598523
  • 财政年份:
    2020
  • 资助金额:
    $ 18.84万
  • 项目类别:
Full-length LRH-1 structural regulation
全长LRH-1结构调整
  • 批准号:
    10697397
  • 财政年份:
    2020
  • 资助金额:
    $ 18.84万
  • 项目类别:
A new kinase inhibitor for glioblastoma
一种新的胶质母细胞瘤激酶抑制剂
  • 批准号:
    10019480
  • 财政年份:
    2019
  • 资助金额:
    $ 18.84万
  • 项目类别:
Cancer cell signaling through lipids complexed to proteins
通过脂质与蛋白质复合的癌细胞信号传导
  • 批准号:
    8543686
  • 财政年份:
    2012
  • 资助金额:
    $ 18.84万
  • 项目类别:
Cancer cell signaling through lipids complexed to proteins
通过脂质与蛋白质复合的癌细胞信号传导
  • 批准号:
    8708521
  • 财政年份:
    2012
  • 资助金额:
    $ 18.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了